Domenico Alvaro Selected Research

von Willebrand Factor

7/2021

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Domenico Alvaro Research Topics

Disease

34	Cholangiocarcinoma 09/2023 - 12/2005
22	Neoplasms (Cancer) 01/2022 - 12/2005
19	Liver Diseases (Liver Disease) 01/2023 - 10/2004
19	Cholestasis 01/2022 - 07/2002
17	Fibrosis (Cirrhosis) 04/2024 - 10/2003
12	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2023 - 04/2004
9	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 02/2009
7	Inflammation (Inflammations) 09/2022 - 10/2004
7	Sclerosing Cholangitis 01/2022 - 06/2013
5	Hyperplasia 10/2011 - 05/2007
4	COVID-19 06/2022 - 01/2020
3	Non-alcoholic Fatty Liver Disease 09/2022 - 12/2012
2	Ascites 04/2024 - 11/2022
2	Hepatic Encephalopathy 04/2024 - 10/2023
2	Hemorrhage 04/2024 - 06/2021
2	Thrombosis (Thrombus) 04/2024 - 01/2022
2	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 04/2010
2	Opioid-Induced Constipation 06/2022 - 12/2020
2	Disease Progression 01/2022 - 08/2017
2	Body Weight (Weight, Body) 01/2020 - 08/2009
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020 - 11/2016
2	Infections 09/2017 - 06/2016
2	Liver Neoplasms (Liver Cancer) 01/2017 - 02/2014
2	Carcinogenesis 04/2013 - 08/2008
2	Necrosis 08/2011 - 10/2004
2	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2010 - 02/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2009 - 10/2007
1	Portal Hypertension 04/2024
1	End Stage Liver Disease 01/2023
1	Tyrosinemias (Tyrosinemia) 01/2022
1	Obesity 01/2022
1	Choledocholithiasis 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Hepatitis 01/2022

Drug/Important Bio-Agent (IBA)

8	Secretin FDA Link 01/2023 - 04/2003
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2007
7	secretin receptorIBA 01/2023 - 04/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 12/2005
5	Bicarbonates (Hydrogen Carbonate)IBA 01/2023 - 04/2002
5	Alkaline PhosphataseIBA 11/2022 - 01/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2009
5	Bile Acids and Salts (Bile Acids)IBA 11/2020 - 10/2002
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 08/2017
4	Messenger RNA (mRNA)IBA 10/2021 - 05/2010
4	CollagenIBA 07/2021 - 12/2005
4	MucinsIBA 01/2019 - 06/2012
4	Estrogens (Estrogen)FDA Link 02/2008 - 07/2002
3	BilirubinIBA 11/2022 - 01/2010
3	MicroRNAs (MicroRNA)IBA 01/2020 - 11/2018
3	Serotonin (5 Hydroxytryptamine)IBA 05/2010 - 01/2005
3	Insulin-Like PeptidesIBA 05/2009 - 09/2006
3	Hormones (Hormone)IBA 02/2009 - 08/2008
3	Estrogen ReceptorsIBA 02/2008 - 12/2004
2	Chloride-Bicarbonate AntiportersIBA 01/2023 - 04/2010
2	obeticholic acidIBA 11/2022 - 04/2021
2	VaccinesIBA 06/2022 - 11/2021
2	Opioid Analgesics (Opioids)IBA 06/2022 - 12/2020
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 04/2002
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 04/2002
2	nasIBA 01/2022 - 12/2012
2	Insulin (Novolin)FDA Link 01/2021 - 01/2015
2	LipopolysaccharidesIBA 12/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 02/2008
2	Amylases FDA Link 01/2017 - 05/2009
2	Nerve Growth Factor (NGF)IBA 01/2016 - 10/2004
2	Thioacetamide (Thioacetamid)IBA 02/2012 - 08/2008
2	MelatoninIBA 10/2011 - 10/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2011 - 02/2008
2	NeuropeptidesIBA 08/2011 - 02/2009
2	Transaminases (Aminotransferases)IBA 08/2011 - 01/2010
2	EnzymesIBA 05/2010 - 11/2008
2	Vascular Endothelial Growth Factor CIBA 08/2009 - 12/2005
2	Mitogen-Activated Protein Kinase 3IBA 08/2008 - 12/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2007 - 09/2006
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2007 - 12/2005
2	Inositol (Myoinositol)IBA 04/2006 - 12/2005
1	Rifaximin (L 105)FDA Link 10/2023
1	LipidsIBA 12/2022
1	AlbuminsIBA 11/2022
1	Methionine (L-Methionine)FDA Link 09/2022
1	Mineral WatersIBA 09/2022
1	Choline (Choline Chloride)IBA 09/2022
1	Calcium Sulfate (Alabaster)IBA 09/2022
1	HydrolasesIBA 01/2022
1	NanogelsIBA 01/2022
1	Therapeutic UsesIBA 01/2022

Therapy/Procedure

21	Therapeutics 04/2024 - 04/2007
8	Ligation 06/2014 - 10/2003
7	Liver Transplantation 10/2023 - 04/2007
6	Drug Therapy (Chemotherapy) 09/2023 - 11/2008
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 07/2013
3	Transplantation 11/2020 - 12/2014
3	Radiotherapy 12/2010 - 11/2008
2	Immunotherapy 10/2021 - 01/2020
2	Precision Medicine 10/2021 - 05/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2024
1	Critical Care (Surgical Intensive Care) 04/2024
1	Transjugular Intrahepatic Portasystemic Shunt 04/2024
1	Cell Transplantation 01/2023